CVS Drug Buyers Face Skeptical 9th Circ. In $121M Retrial Bid

By Dorothy Atkins · November 15, 2022, 8:32 PM EST

A certified class of insured drug buyers urged the Ninth Circuit on Tuesday to order a new trial after losing claims CVS Pharmacy owes $121 million for overcharging on generic drugs,...

To view the full article, register now.